Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,237,919
-
Share change
-
-4,350,123
-
Total reported value
-
$53,742,476
-
Put/Call ratio
-
75%
-
Price per share
-
$1.57
-
Number of holders
-
70
-
Value change
-
-$12,205,553
-
Number of buys
-
27
-
Number of sells
-
44
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q2 2017
As of 30 Jun 2017,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,237,919 shares.
The largest 10 holders included
BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, PINNACLE ASSOCIATES LTD, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., PLATINUM INVESTMENT MANAGEMENT LTD, MILLENNIUM MANAGEMENT LLC, and Foresite Capital Management III, LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.